| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8594161 | Journal of Stroke and Cerebrovascular Diseases | 2018 | 13 Pages |
Abstract
These results suggest that hASCs in the implanted dose modulate inflammation, promote endogenous neurogenesis, and do not proliferate or migrate in the brain. These data confirm the safety of cell therapy with hASCs.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Ulises PhD, Leyre MDV, PhD, MarÃa Soledad PhD, Cristina MDV, Gonzalo PhD, Fernando José MD, Jone PhD, Begoña PhD, Lidia PhD, Maite PhD, Jordi A. MD, PhD, Jorge MD, PhD, Juan A. MD, PhD,